Underlying diseases, pathogenic bacteria, clinical background and outcome were studied during 91 febrile episodes complicated by sepsis in 55 patients with hematological malignancies, who had been admitted to our hospital (Jikei University Kashiwa Hospital) betweeen January 1990 and December 1994. Particularly in patients with P. aeruginosa sepsis, we compared the prophylactic effect of ciprofloxacin (CPFX) alone with that of the combination of polymyxin B (PL-B) plus kanamycin (KM).
Introduction
Treatment of hematological malignancies has made considerable progress over the years, which has been paralleled by increased long-term survival, including that of patients undergoing bone marrow transplantation.
Potent antitumor chemotherapy, however, causes an extreme decrease in granulocytes, which is unavoidably associated with serious infectious diseases, such as sepsis. Although advances in antibiotic chemotherapy have ensured considerable success in the control of infectious diseases at the time of granulocyte decrease, infectious diseases are still a major detrimental factor during the treatment of hematological malignancies°. Prevention of infection is therefore as important as its treatment. It is also important to study past data concerning infectious diseases in order to establish better treatment and preventive measures. 50 jig/ml or more, indicating that all strains were resistant to it. KM therefore cannot be very useful in preventing P. aeruginosa sepsis. The MIC of SBT/CPZ was 6.25,ug/ml or more, indicating that the organisms tended to be resistant to SBT/CPZ. The antibacterial activity and absorption of CPFX yielded better results than those with PL-B or KM.
Discussion
Patients with hematological malignancies tend to suffer from serious infectious diseases, such as sepsis, secondary to granulocytopenia caused by antitumor chemotherapy or mucosal damage in the digestive tract, as well as suppressed immune function due to the original diseases. In general, when the peripheral granulocyte count falls below 1000/,ul, the frequency of infectious complications increases; when it falls below 500/pl, serious infectious diseases are more likely to occur; and at less then 100/sal;, lethal infections will occur easily3). In infections associated with a decrease in granulocytes, fever is the only complaint; infectious lesions are not identified and pathogenic bacteria are only rarely found on blood culture. According to past results, isolation of pathogenic bacteria by blood culture and diagnosis of sepsis were made in only approximately 20% of patients with granulocytopenia-related fever. The rest of the patients were either "suspected of sepsis" or diagnosed as having "fever of unknown origin". Such fever is commonly normalized after antibiotic or antifungal treatment. Autopsies have revealed the presence of infectious dieseases in fatal cases. The fever is therefore suspected of resulting from bacterial or fungal infections°. Therefore, some researchers advocate that fever at the time of a decrease in granulocytes should be defined as "fever with granulocytopenia" so as to be classified separately from general fever of unknown origin6). Fever at the time of a decrease in granulocytes can be related to sepsis and early empiric therapy with antimicrobial agents must be employed. Past data are important in making the choice of antimicrobial agents. Infections caused by gram-negative bacteria were the issue in the 1970's, whereas those caused by gram-positive bacteria increased in the 1980's7). Introduction of antimicrobial agents with excellent antibacterial activity against gram-negative bacteria, such as the third-generation cephalosporine and carbapenems, enabled control of infections caused by gramnegative bacteria. However, these types of agents have a less potent effect against gram-positive bacteria, which led to the increase in gram-positive bacteria. Our data showed the same tendency: approximately two-thirds of the causal bacteria were gram-positive bacteria, mainly coagulasenegative staphylococci, S. aureus including MRSA, and Streptococcus spp. The outcome of sepsis caused by gram-positive bacteria was not always bad, partly because coagulase-negative staphylococci are basically weakly virulent and may have been incorporated during blood collection for blood culture, partly because vancomycin was available for intravenous infusion against MRSA, and partly because there were no highly resistant bacteria among the Streptococcus spp.
In contrast, sepsis caused by gram-negative bacteria was less common, but its outcome was extremely bad. Seven of the 13 patients with sepsis caused by P. aeruginosa (53.7%) died. This was the highest mortality rate. Toyama stated that, even though the sensitivity of bacteria to antibiotics used in the treatment of gram-positive bacterial sepsis at the time of granulocyte decrease may not be high, the mortality rate is low, while mortality resulting from sepsis caused by gram-negative bacteria, especially P. aeruginosa, is very high when the antibiotic treatment is not effective against the causal bacteria. He therefore added that antibiotics effective against P. aerugionosa must be selected8). His remarks coincide with our findings. An unfavorable outcome can be attributed to the fact that, since only granulocytes phagocytize P. aeruginosa, sepsis rapidly worsened at the time of a decrease in granulocytes, and resulted in shock. Also antibiotics such as vancomycin in the case of MRSA were not avaialable. With respect to P. aeruginosa sepsis, prophylaxis is as important as treatment.
It is clear that P. aeruginosa sepsis at the time of a decrease in granulocytes is an endogenous infection via the digestive tract. Damp circumstans faver P. aeruginosa and it is frequently present in rest rooms. These bacteria possibly enter the body via drinking water, vegetables or other food, and stay in the digestive tract9). While P. aeruginosa hardly ever becomes pathogenic in normal healthy humans, it causes sepsis in patients with decreased granulocyte counts. Moreover, patients with hematological malignancies have a greater chance of having P. aeruginosa in the intestine than normal humans because they receive antibiotics more frequently9).
To prevent endogenous infection at the time of granulocyte decrease, the inside of the digestive tract must be made aseptic. Digestive tract decontamination comprises total decontamination to inhibit all pathogenic microorganisms or selective decontamination to preserve anaerobes while inhibiting aerobic gram-nagative becteria and fungi10). The former is performed to make the patient' s whole body aseptic before the patients is placed in a sterile room prior to bone marrow transplantation; the latter is selected for ordinary chemotherapy. Sulfametoxazole/trimetoprim11) , PL-B12) and aminoglycosidesl3) have been used separately or in combination, so far without satisfactory effects . P. aeruginosa sepsis often develops even when the above agents are administered. We selected CPFX from the new quinolones because of its high antibacterial activity against P. aeruginosa and its minor effect against anaerobes which are easily absorbed from the digestive tract. We also retrospectively compared the prophylactic effect of CPFX with that of PL-B plus KM on P. aeruginosa sepsis. While 13 episodes of P. aeruginosa sepsis were found in patients receiving PL-B plus KM , no such episode was found in CPFX-treated patients. Comparison of the antibacterial activity against 7 P. aeruginosa strains isolated in our study revealed that CPFX was slightly better than PL-B, but that PL-B was not much worse than CPFX since high PL-B resistance was observed in only 1 strain , However, the slight difference is attributable to the difference in absorption between the 2 agents. Sepsis caused by gram-positive bacteria still occurs and current antibotics are still unsatisfactory in preventing it. Several studies have compared the preventive effect of new quinolone and PL-B on infections at the time of granulocyte decrease. The new quinolones tested were CPFX14) in our study, norfloxacinl5)-18), and tosufloxacin3). Though a decreased rate of detection of gram-negative bacteria was shown in all reports, no significant difference was found in the rate of detection of gram-positive bacteria, the incidence of fever, or the duration of intravenous antibiotic administration . We did not include fever or the duration of intravenous antibiotic administration in our study, as we only studied patients with sepsis. The findings that gram-negative bacteria decreased and that there was no change in gram-positive bacteria agree with previous data. In conclusion, the administration of CPFX against infections at the time of granulocyte decrease was adequately effective against gram-negative bacteria, but its effect on gram-positive bacteria was unsatisfactory.
Nalidixic acid synthesized in 1962 was the first quinolone derivative developed. An abstract of this study was presented at the 69th Genearl Meeting of the Japanese Assosiation for Infectious Diseases (Fukuoka).
